Treatment of conjunctival mucosa-associated lymphoid tissue lymphoma with intralesional injection of interferon alfa-2b.
Lachapelle
K R
KR
Department of Ophthalmology, Queen's University, Kingston, Ontario, Canada.
Rathee
R
R
Kratky
V
V
Dexter
D F
DF
D000328:Adult; D015703:Antigens, CD / Q000032:analysis; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003230:Conjunctival Neoplasms / Q000737:chemistry / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D016130:Immunophenotyping; D015552:Injections, Intralesional; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D018442:Lymphoma, B-Cell, Marginal Zone / Q000737:chemistry / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D011994:Recombinant Proteins
D015703:Antigens, CD; D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins